期刊
MOLECULAR THERAPY
卷 16, 期 10, 页码 1688-1694出版社
CELL PRESS
DOI: 10.1038/mt.2008.164
关键词
-
资金
- National Institutes of Health [EY13729, EY11123, NS36302, EY08571, EY016073, HL56921]
- Macular Vision Research Foundation
- Foundation Fighting Blindness
- Juvenile Diabetes Research Foundation
- Research to Prevent Blindness, Inc.
- University of Florida
- NATIONAL EYE INSTITUTE [U10EY013729, R01EY011123, R01EY018335, P30EY008571, R01EY016073] Funding Source: NIH RePORTER
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056921] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS036302] Funding Source: NIH RePORTER
Choroidal neovascularization (CNV) occurs in a variety of chorioretinal diseases including age-related macular degeneration (AMD), and is the major cause of severe visual loss in patients with AMD. Oxidative stress has been thought to play an important role in the development of CNV. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is one of the major intracellular sources of reactive oxygen species (ROS) in the vascular system. In this study, we examined the expression of p22phox, an integral subunit in the NADPH oxidase complex, in the mouse eye. We determined that p22phox is expressed in the retinal pigment epithelial (RPE) cells and inner retinal neurons. A small-interfering RNA (siRNA) designed against p22phox efficiently reduced the expression of the protein in the eye when delivered by means of recombinant adeno-associated virus (AAV) vector. Vector treatment inhibited CNV in the mouse when delivered into the subretinal space where RPE cells were transduced. These results suggest that NADPH oxidase-mediated ROS production in RPE cells may play an important role in the pathogenesis of neovascular AMD, and that this pathway may represent a new target for therapeutic intervention in AMD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据